The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The usefulness and efficacy of cisplatin, a chemotherapeutic drug, are limited by its toxicity to normal tissues and organs, including the kidneys. The uptake of cisplatin in renal tubular cells is high, leading to cisplatin accumulation and tubular cell injury and death, culminating in acute renal failure. While extensive investigations have been focused on the signaling pathways of cisplatin nephrotoxicity, much less is known about the mechanism of cisplatin uptake by renal cells and tissues. In this regard, evidence has been shown for the involvement of organic cation transporters (OCT), specifically OCT2. The copper transporter Ctr1 is highly expressed in the renal tubular cells; however, its role in cisplatin nephrotoxicity is not known. In this study, we demonstrate that Ctr1 is mainly expressed in both proximal and distal tubular cells in mouse kidneys. We further show that Ctr1 is mainly localized on the basolateral side of these cells, a proposed site for cisplatin uptake. Importantly, downregulation of Ctr1 by small interfering RNA or copper pretreatment results in decreased cisplatin uptake. Consistently, downregulation of Ctr1 suppresses cisplatin toxicity, including cell death by both apoptosis and necrosis. Cimetidine, a pharmacological inhibitor of OCT2, can also partially attenuate cisplatin uptake. Notably, cimetidine can further reduce cisplatin uptake and cisplatin toxicity in Ctr1-downregulated cells. The results have demonstrated the first evidence for a role of Ctr1 in cisplatin uptake and nephrotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
Self-citationUptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162491399 · Cited by 927
Arany, I., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00089-5 · Cited by 906
Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development
Lee, J., Prohaska, J. R., & Thiele, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111058698 · Cited by 472
Lieberthal, W., Triaca, V., & Levine, J. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.4.f700 · Cited by 449
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways
Cummings, B. S., & Schnellmann, R. G. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.8 · Cited by 358
Holzer, A. K., Manorek, G. H., & Howell, S. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022624 · Cited by 322
ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis
Pabla, N., Huang, S., Mi, Q.-S., Daniel, R., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707568200 · Cited by 309
Self-citationThe roles of copper transporters in cisplatin resistance
Kuo, M. T., Chen, H. H. W., Song, I.-S., Savaraj, N., & Ishikawa, T. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9045-3 · Cited by 283
Activation and involvement of p53 in cisplatin-induced nephrotoxicity
Wei, Q., Dong, G., Yang, T., Megyesi, J., Price, P. M., & Dong, Z. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00230.2007 · Cited by 232
Self-citationThe Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Lin, X., Okuda, T., Holzer, A., & Howell, S. B. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1154 · Cited by 232
The pathological role of Bax in cisplatin nephrotoxicity
Wei, Q., Dong, G., Franklin, J., & Dong, Z. (2007) · Kidney International · doi:10.1038/sj.ki.5002256 · Cited by 228
Self-citationCopper Transport Protein (Ctr1) Levels in Mice Are Tissue Specific and Dependent on Copper Status
Kuo, Y.-M., Gybina, A. A., Pyatskowit, J. W., Gitschier, J., & Prohaska, J. R. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.1.21 · Cited by 218
Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis
Jiang, M., Wei, Q., Wang, J., Du, Q., Yu, J., Zhang, L., & Dong, Z. (2006) · Oncogene · doi:10.1038/sj.onc.1209440 · Cited by 209
Self-citationLee, J., Prohaska, J. R., Dagenais, S. L., Glover, T. W., & Thiele, D. J. (2000) · Gene · doi:10.1016/s0378-1119(00)00287-0 · Cited by 203
Guo, Y., Smith, K., Lee, J., Thiele, D. J., & Petris, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401493200 · Cited by 188
Yonezawa, A., Masuda, S., Nishihara, K., Yano, I., Katsura, T., & Inui, K.-I. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.020 · Cited by 180
Nephrotoxicity of platinum complexes is related to basolateral organic cation transport
Ludwig, T., Riethmüller, C., Gekle, M., Schwerdt, G., & Oberleithner, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00720.x · Cited by 179
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
Jiang, M., Yi, X., Hsu, S., Wang, C.-Y., & Dong, Z. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00262.2004 · Cited by 175
Self-citationJiang, M., Wei, Q., Pabla, N., Dong, G., Wang, C., Yang, T., Smith, S. B., & Dong, Z. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.010 · Cited by 149
Self-citationHolzer, A. K., Katano, K., Klomp, L. W. J., & Howell, S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0748 · Cited by 143
Human Copper Transporter hCTR1 Mediates Basolateral Uptake of Copper into Enterocytes
Zimnicka, A. M., Maryon, E. B., & Kaplan, J. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702653200 · Cited by 102
Structure of the Ctr1 copper trans‘PORE’ter reveals novel architecture
Nose, Y., Rees, E. M., & Thiele, D. J. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.09.003 · Cited by 98
Characterization of regulatory mechanisms and states of human organic cation transporter 2
Biermann, J., Lang, D., Gorboulev, V., Koepsell, H., Sinđić, A., Schröter, R., Žvirblienė, A., Pavenstädt, H. J., Schlatter, E., & Ciarimboli, G. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00622.2005 · Cited by 69
Bhatt, K. S., Feng, L., Pabla, N., Liu, K., Smith, S. B., & Dong, Z. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00415.2007 · Cited by 47
Self-citation
Cited by
Mechanisms of Cisplatin Nephrotoxicity
Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,622
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Ozkok, A., & Edelstein, C. L. (2014) · BioMed Research International · doi:10.1155/2014/967826 · Cited by 703
Cisplatin nephrotoxicity: a review of the literature
Manohar, S., & Leung, N. (2018) · Journal of Nephrology · doi:10.1007/s40620-017-0392-z · Cited by 636
Cisplatin nephrotoxicity: new insights and therapeutic implications
Tang, C., Livingston, M. J., Safirstein, R., & Dong, Z. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00631-7 · Cited by 548
Self-citation
Metadata
- Authors
- Pabla, N., Murphy, R. F., Liu, K., & Dong, Z.
- Venue
- American Journal of Physiology-Renal Physiology
- Publisher
- American Physiological Society
- Published
- 2009-03
- Volume
- 296
- Issue
- 3
- Pages
- F505-F511
- ISSN
- 1522-1466 (ISSN-L)
- 1931-857X
- OpenAlex
- W1971492805
- Cited by
- 283
- References
- 28
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.